More people die from viral hepatitis than from HIV, yet the public health response is lacking. The ACHIEVE Coalition urges governments in Europe and elsewhere to improve hepatitis B and hepatitis C monitoring so that a reliable evidence base will be available to guide the drive towards disease elimination.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
World Health Organization. Global Hepatitis Report 2017 (WHO, 2017).
Duffell, E. F., Hedrich, D., Mardh, O. & Mozalevskis, A. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions. Euro Surveill. 22, 30476 (2017).
Lazarus, J. V., Mozalevskis, A., Safreed-Harmon, K. & Eramova, I. Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014). Hepatol. Med. Policy, 1, 3 (2016).
Rantala, M. & van de Laar, M. J. W. Surveillance and epidemiology of hepatitis B and C in Europe — a review. Euro Surveill. 22, 18880 (2008).
Duffell, E. F., van de Laar, M. J. W. & Amato-Gauci, A. J. Enhanced surveillance of hepatitis B in the EU, 2006–2012. J. Viral Hepat. 22, 581–589 (2015).
European Centre for Disease Prevention and Control. Hepatitis B and C testing activities, needs, and priorities in the EU/EEA (ECDC, 2017).
The ACHIEVE Coalition is enabled by the support of Abbott, Cepheid, Gilead Sciences and MSD. None of the authors received funding for their work on this Comment.
About this article
Cite this article
Lazarus, J., Safreed-Harmon, K., Colombo, M. et al. Many European countries 'flying blind' in their efforts to eliminate viral hepatitis. Nat Rev Gastroenterol Hepatol 14, 445–446 (2017). https://doi.org/10.1038/nrgastro.2017.98